{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:35:42Z","timestamp":1717720542047},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,5]]},"DOI":"10.7759\/cureus.61767","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T05:09:16Z","timestamp":1717650556000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute-Onset Blindness in a Patient Diagnosed With Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOG-AD): A Case Report"],"prefix":"10.7759","author":[{"given":"Frederick","family":"Gyabaah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrena","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhizith","family":"Deoker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519837705","article-title":"MOG antibody-associated encephalomyelitis\/encephalitis","volume":"25","author":"Salama S","year":"2019","unstructured":"Salama S, Khan M, Pardo S, Izbudak I, Levy M. MOG antibody-associated encephalomyelitis\/encephalitis. Mult Scler. 2019, 25:1427-33. 10.1177\/1352458519837705","journal-title":"Mult Scler"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-9122-2","article-title":"Neurological update: MOG antibody\u00a0disease","volume":"266","author":"Wynford-Thomas R","year":"2019","unstructured":"Wynford-Thomas R, Jacob A, Tomassini V. Neurological update: MOG antibody\u00a0disease. J Neurol. 2019, 266:1280-6. 10.1007\/s00415-018-9122-2","journal-title":"J Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103118","article-title":"Distinct patterns of MRI lesions in MOG antibody disease and AQP4 NMOSD: a systematic review and meta-analysis","volume":"54","author":"Carandini T","year":"2021","unstructured":"Carandini T, Sacchi L, Bovis F, et al.. Distinct patterns of MRI lesions in MOG antibody disease and AQP4 NMOSD: a systematic review and meta-analysis. Mult Scler Relat Disord. 2021, 54:103118. 10.1016\/j.msard.2021.103118","journal-title":"Mult Scler Relat Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk DM","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999, 53:1107-14. 10.1212\/wnl.53.5.1107","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.953993","article-title":"Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: a network meta-analysis","volume":"13","author":"Wang X","year":"2022","unstructured":"Wang X, Kong L, Zhao Z, et al.. Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: a network meta-analysis. Front Immunol. 2022, 13:953993. 10.3389\/fimmu.2022.953993","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius S","year":"2018","unstructured":"Jarius S, Paul F, Aktas O, et al.. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation. 2018, 15:134. 10.1186\/s12974-018-1144-2","journal-title":"J Neuroinflammation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.108","article-title":"The investigation of acute optic neuritis: a review and proposed protocol","volume":"10","author":"Petzold A","year":"2014","unstructured":"Petzold A, Wattjes MP, Costello F, et al.. The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol. 2014, 10:447-58. 10.1038\/nrneurol.2014.108","journal-title":"Nat Rev Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.03.008","article-title":"Patient harm due to diagnostic error of neuro-ophthalmologic conditions","volume":"128","author":"Stunkel L","year":"2021","unstructured":"Stunkel L, Sharma RA, Mackay DD, Wilson B, Van Stavern GP, Newman NJ, Biousse V. Patient harm due to diagnostic error of neuro-ophthalmologic conditions. Ophthalmology. 2021, 128:1356-62. 10.1016\/j.ophtha.2021.03.008","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.5470","article-title":"Incidence and causes of overdiagnosis of optic neuritis","volume":"136","author":"Stunkel L","year":"2018","unstructured":"Stunkel L, Kung NH, Wilson B, McClelland CM, Van Stavern GP. Incidence and causes of overdiagnosis of optic neuritis. JAMA Ophthalmol. 2018, 136:76-81. 10.1001\/jamaophthalmol.2017.5470","journal-title":"JAMA Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117225","article-title":"Neuromyelitis optica spectrum disorders","volume":"420","author":"Paul S","year":"2021","unstructured":"Paul S, Mondal GP, Bhattacharyya R, Ghosh KC, Bhat IA. Neuromyelitis optica spectrum disorders. J Neurol Sci. 2021, 420:117225. 10.1016\/j.jns.2020.117225","journal-title":"J Neurol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/08820538.2020.1866027","article-title":"MRI characteristics of NMO, MOG and MS related optic neuritis","volume":"35","author":"Winter A","year":"2020","unstructured":"Winter A, Chwalisz B. MRI characteristics of NMO, MOG and MS related optic neuritis. Semin Ophthalmol. 2020, 35:333-42. 10.1080\/08820538.2020.1866027","journal-title":"Semin Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103229","article-title":"Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: the difficulty of predicting relapses","volume":"56","author":"Epstein SE","year":"2021","unstructured":"Epstein SE, Levin S, Onomichi K, et al.. Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: the difficulty of predicting relapses. Mult Scler Relat Disord. 2021, 56:103229. 10.1016\/j.msard.2021.103229","journal-title":"Mult Scler Relat Disord"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius S","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I, et al.. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation. 2016, 13:280. 10.1186\/s12974-016-0718-0","journal-title":"J Neuroinflammation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.61.9.1401","article-title":"The natural history of recurrent optic neuritis","volume":"61","author":"Pirko I","year":"2004","unstructured":"Pirko I, Blauwet LA, Lesnick TG, Weinshenker BG. The natural history of recurrent optic neuritis. Arch Neurol. 2004, 61:1401-5. 10.1001\/archneur.61.9.1401","journal-title":"Arch Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato DK","year":"2014","unstructured":"Sato DK, Callegaro D, Lana-Peixoto MA, et al.. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology. 2014, 82:474-81. 10.1212\/WNL.0000000000000101","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104498","article-title":"Factors associated with the misdiagnosis of neuromyelitis optica spectrum disorder","volume":"70","author":"Smith AD","year":"2023","unstructured":"Smith AD, Moog TM, Burgess KW, McCreary M, Okuda DT. Factors associated with the misdiagnosis of neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2023, 70:104498. 10.1016\/j.msard.2023.104498","journal-title":"Mult Scler Relat Disord"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10236-4","article-title":"Efficacy and safety of long-term immunotherapy in adult patients with MOG antibody disease: a systematic analysis","volume":"268","author":"Lu Q","year":"2021","unstructured":"Lu Q, Luo J, Hao H, Liu R, Jin H, Jin Y, Gao F. Efficacy and safety of long-term immunotherapy in adult patients with MOG antibody disease: a systematic analysis. J Neurol. 2021, 268:4537-48. 10.1007\/s00415-020-10236-4","journal-title":"J Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1013413","article-title":"Case report: MOG-IgG-associated encephalitis with Epstein-Barr virus infection and Alzheimer's pathologic change in cerebrospinal fluid","volume":"13","author":"Li L","year":"2022","unstructured":"Li L, Li C, Yao D, et al.. Case report: MOG-IgG-associated encephalitis with Epstein-Barr virus infection and Alzheimer's pathologic change in cerebrospinal fluid. Front Neurol. 2022, 13:1013413. 10.3389\/fneur.2022.1013413","journal-title":"Front Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/206268-acute-onset-blindness-in-a-patient-diagnosed-with-myelin-oligodendrocyte-glycoprotein-antibody-disease-mog-ad-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T05:09:19Z","timestamp":1717650559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/206268-acute-onset-blindness-in-a-patient-diagnosed-with-myelin-oligodendrocyte-glycoprotein-antibody-disease-mog-ad-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.61767","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,5]]}}}